Superworth

Mimedx price to book ratio MDXG

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
2.6×
10-year median
5.6×
Against its 10-year history
13th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.9× to 91.3×
Peer median
3.1×

Mimedx's price to book ratio is 2.6× as of Oct 23, 2026.

That is below its ten-year median of 5.6×, lower than on 87% of days in the last ten years.

Over that time it ranged from 0.9× in Dec 2018 to 91.3× in Mar 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 3.1×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.6×2.0×4.0×
20254.3×4.2×7.5×
20247.6×5.0×8.9×
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
202191.3×75.7×91.3×
202078.3×4.0×82.5×
20195.7×1.6×5.8×
20181.2×0.9×13.4×
20179.8×6.8×13.5×
20167.9×6.5×9.3×
201510.2×8.4×16.3×
201414.9×7.5×23.2×
201323.1×11.4×31.6×
201217.4×6.7×17.4×
20117.1×5.8×7.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.

CompanyPrice to book ratio
MDXGMimedx2.6×
TCMDTactile Systems Technology2.4×
MOVMovado1.4×
EMBCEmbectan/m
IRMDIradimed10.8×
STAAStaar Surgical3.1×
INFUInfuSystem4.7×
BVSBioventus5.5×
CDRECadre3.7×
UTMDUtah Medical Products1.9×
EYENational Vision1.6×
Peer median3.1×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Mimedx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.